Literature DB >> 12586615

Sphingosine 1-phosphate is a novel inhibitor of T-cell proliferation.

Yixin Jin1, Eirunn Knudsen, Ling Wang, Yenan Bryceson, Bassam Damaj, Sandra Gessani, Azzam A Maghazachi.   

Abstract

Sphingosine 1-phosphate (S1P) is a pleiotropic lysosphingophospholipid stored and secreted by platelets. Using reverse transcription-polymerase chain reaction and flow cytometric analyses, we determined the expression of S1P receptors (S1P1, S1P3, S1P4, and S1P5) in peripheral blood T cells. T cells were induced to proliferate in the presence of phorbol 12-myristate 13-acetate (PMA) plus ionomycin, anti-CD3 plus anti-CD28, and allogeneic immature or mature dendritic cells. This activity was inhibited by the addition of S1P. Enhanced T-cell proliferation was observed when these cells were stimulated with the same stimuli, but were incubated in serum-free media (SFM). Addition of S1P to SFM inhibited the stimulation of T cells induced by T-cell stimuli, suggesting that S1P is an important inhibitory molecule present in the serum. T-cell proliferation was also inhibited by the addition of dihydrosphingosine 1-phosphate (DHS1P), sphingosine, and ceramide; however, the latter 2 sphingolipids required higher concentrations than S1P. Pretreatment of T cells with pertussis toxin (PTX) blocked the inhibitory effect of S1P on activation with PMA plus ionomycin, but not on activation with anti-CD3 plus anti-CD28. This is corroborated with the down-regulation of S1P1 in T cells stimulated with anti-CD3 plus anti-CD28. Similarly, PTX did not affect the inhibitory effect of S1P on T-cell proliferation when dendritic cells were used as stimuli. Further, S1P or DHS1P but not ceramide or sphingosine enhanced rather than decreased secretion of interleukin 2 and interferon gamma by T cells stimulated with anti-CD3 plus anti-CD28. These results show differential effects of S1P on polyclonal T-cell proliferation and cytokine secretion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12586615     DOI: 10.1182/blood-2002-09-2962

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

1.  Identification of lectin-like receptors expressed by antigen presenting cells and neutrophils and their mapping to a novel gene complex.

Authors:  Line Mari Flornes; Yenan T Bryceson; Anne Spurkland; Johnny C Lorentzen; Erik Dissen; Sigbjørn Fossum
Journal:  Immunogenetics       Date:  2004-09-11       Impact factor: 2.846

Review 2.  Sphingosine 1-phosphate signaling impacts lymphocyte migration, inflammation and infection.

Authors:  Irina V Tiper; James E East; Priyanka B Subrahmanyam; Tonya J Webb
Journal:  Pathog Dis       Date:  2016-06-27       Impact factor: 3.166

3.  T cell inhibitory mechanisms in a model of aggressive Non-Hodgkin's Lymphoma.

Authors:  Tamara Hilmenyuk; Carla A Ruckstuhl; Michael Hayoz; Christian Berchtold; Jean-Marc Nuoffer; Shyam Solanki; Hector C Keun; Paul A Beavis; Carsten Riether; Adrian F Ochsenbein
Journal:  Oncoimmunology       Date:  2017-09-21       Impact factor: 8.110

4.  Sphingosine Kinase 2 Deficiency Attenuates Kidney Fibrosis via IFN-γ.

Authors:  Amandeep Bajwa; Liping Huang; Elvira Kurmaeva; Hong Ye; Krishna R Dondeti; Piotr Chroscicki; Leah S Foley; Z Ayoade Balogun; Kyle J Alexander; Hojung Park; Kevin R Lynch; Diane L Rosin; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2016-10-31       Impact factor: 10.121

5.  Maternal exposure to soy diet reduces atheroma in hyperlipidemic F1 offspring mice by promoting macrophage and T cell anti-inflammatory responses.

Authors:  Ramona L Burris; Sarah C Vick; Branimir Popovic; Pamelia E Fraungruber; Shanmugam Nagarajan
Journal:  Atherosclerosis       Date:  2020-09-22       Impact factor: 5.162

Review 6.  Sphingolipids in spinal cord injury.

Authors:  Zachary B Jones; Yi Ren
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-08-05

7.  PAM mediates sustained inhibition of cAMP signaling by sphingosine-1-phosphate.

Authors:  Sandra C Pierre; Julia Häusler; Kerstin Birod; Gerd Geisslinger; Klaus Scholich
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

Review 8.  The alliance of sphingosine-1-phosphate and its receptors in immunity.

Authors:  Juan Rivera; Richard L Proia; Ana Olivera
Journal:  Nat Rev Immunol       Date:  2008-10       Impact factor: 53.106

Review 9.  Lyase to live by: sphingosine phosphate lyase as a therapeutic target.

Authors:  Ashok Kumar; Julie D Saba
Journal:  Expert Opin Ther Targets       Date:  2009-08       Impact factor: 6.902

10.  Regulatory activity of azabisphosphonate-capped dendrimers on human CD4+ T cell proliferation enhances ex-vivo expansion of NK cells from PBMCs for immunotherapy.

Authors:  Damien Portevin; Mary Poupot; Olivier Rolland; Cédric-Olivier Turrin; Jean-Jacques Fournié; Jean-Pierre Majoral; Anne-Marie Caminade; Remy Poupot
Journal:  J Transl Med       Date:  2009-09-24       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.